Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can reduced ALA conversion contribute to low EPA despite normal DHA?

Reduced conversion of ALA to EPA can contribute to low EPA even when DHA is within range.

PlausibleNovember 21, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Reduced endogenous conversion of alpha-linolenic acid to EPA can contribute to low circulating or erythrocyte EPA despite DHA being within range.

laying out figure…
0 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

ALA conversion to EPA is generally limited and varies with factors including genetics and dietary intake. EPA and DHA can vary independently, and the evidence for conversion affecting EPA is stronger in plasma than in red blood cells.

Verified conclusion

Reduced conversion of dietary alpha-linolenic acid (ALA) to eicosapentaenoic acid (EPA) is a credible contributor to low EPA status, including when DHA is within a laboratory reference range. The evidence is strongest for plasma EPA; red-cell findings support the possibility but are less consistent.

Clinical and biomarker evidence

  • Stable-isotope studies confirm endogenous ALA-to-EPA conversion in humans, though it is generally limited—often estimated at up to roughly 7% of ingested ALA—and varies by analytic method, sampling time, and lipid compartment.
  • Controlled dietary studies show that increasing ALA can increase plasma EPA and, in some interventions, red-cell EPA. A systematic review likewise found EPA increases in most ALA-enrichment trials.
  • These findings indicate that conversion efficiency can materially influence EPA concentrations, particularly when preformed EPA intake is low.

Mechanistic and genetic evidence

  • The FADS1/FADS2 region encodes enzymes central to long-chain polyunsaturated-fatty-acid metabolism. In a controlled-diet tracer study, major-allele carriers had approximately 3–4-fold higher labeled plasma EPA formation than minor-allele carriers.
  • Across five cohorts, FADS minor alleles were associated with higher plasma-phospholipid ALA and lower EPA and DPA—an expected biochemical pattern for reduced conversion.
  • EPA and DHA need not track together: ALA interventions have raised EPA without raising DHA, and one intervention increased red-cell EPA while DHA declined. Limited conversion onward from EPA toward DHA provides a mechanistic basis for this dissociation.

Clinical interpretation

  • Bottom line: A normal DHA result does not exclude impaired or relatively low ALA-to-EPA conversion as a contributor to low EPA. It should be viewed as one determinant among dietary preformed EPA/DHA intake, ALA intake, genotype, and other physiologic influences; the inference is better supported for circulating plasma EPA than for erythrocyte EPA.

References

  1. Quantifying conversion of alpha-linolenic acid (ALA) to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA): a systematic review of animal and human studies utilizing carbon-13 ALA - Lipids in Health and Disease — link.springer.com ↗
  2. Molecular Insights into the Functional Roles of Variants in the FADS Gene Cluster on Omega-3 Long-Chain Polyunsaturated Fatty Acid Synthesis — ncbi.nlm.nih.gov ↗
  3. Genetic association between FADS and ELOVL polymorphisms and the circulating levels of EPA/DHA in humans: a scoping review - Genes & Nutrition — genesandnutrition.biomedcentral.com ↗
  4. Flaxseed oil increases the plasma concentrations of cardioprotective ... — pubmed.ncbi.nlm.nih.gov ↗
  5. Genetic Loci Associated with Plasma Phospholipid n-3 Fatty ... — journals.plos.org ↗
  6. Effects of a 12-week high-α-linolenic acid intervention on ... — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible2 sourcesCan disrupted sleep and circadian rhythms contribute to insulin resistance?→Plausible4 sourcesCan sustained cortisol excess contribute to insulin resistance?→